YUMAB continuously improves its technologies by combining cutting edge technologies with proprietary innovations to extent its portfolio of antibody development technologies even beyond phage display.
New antibody development technologies in 2019
- Update of phage display scFv antibody library
- New antibody phage display library in Fab format
- New humanized mice system for antibody development against “difficult” or conserved antigens